
GC10474
Laquinimod
Also listed as Laquinimod (ABR-215062)
Laquinimod (ABR-215062) (ABR-215062), an orally available carboxamide derivative, is a potent immunomodulator which prevents neurodegeneration and inflammation in the central nervous system
ChemicalCAS248281-84-7MW356.8FormulaC19H17ClN2O3
- CAS number
- 248281-84-7
- Molecular weight
- 356.8
- Formula
- C19H17ClN2O3
- Solubility
- ≥ 17·25mg/mL in DMSO
- InChIKey
- GKWPCEFFIHSJOE-UHFFFAOYSA-N
- Catalogue number
- GC10474
- Brand
- GLPBIO
Computed properties PubChem CID 54677946 · XLogP 3.7 · TPSA 60.9 Ų · H-bond donors 1
- XLogP
- 3.7
- TPSA
- 60.9 Ų
- H-bond donors
- 1
- H-bond acceptors
- 3
- Rotatable bonds
- 3
- Heavy atoms
- 25
SMILES CCN(C1=CC=CC=C1)C(=O)C2=C(C3=C(C=CC=C3Cl)N(C2=O)C)O
Computed descriptors from PubChem (CID 54677946), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il